Mapatumumab(TD-HT017016) is a research-grade recombinant antibody targetingCD261. Produced in mammalian cells with native-like glycosylation.HighlightsResearch Grade— For PK/PD studies, assay development, and ADA research.Native Glycosylation— Mammalian expression ensures native-like patterns.
Species reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Protein A/G purified from cell culture supernatant.
Accession
O00220
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names
HGS-ETR1, TRM-1, 658052-09-6
Background
Mapatumumab (HGS-ETR1) is a fully human IgG1 agonistic monoclonal antibody that targets tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1). Mapatumumab can be used for the research of cancer.
Caption
SEC-HPLC detection for Research Grade Mapatumumab. | SDS-PAGE for Research Grade Mapatumumab. | Western blot analysis was performed using anti-CD261/TNFRSF10A monoclonal antibody at 1ug/mL on various samples.Lane 1:recombinant human CD261/TNFRSF10A (Catalog No:TD-HT017011)Lane 2:negative control
Note
For research use only. Not suitable for clinical or therapeutic use.